相关实验视频

Updated: Apr 14, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

人类瘤免疫学和免疫疗法的进展

S A Rosenberg¹

¹Division of Clinical Sciences, National Cancer Institute, Building 10, Room 2B42, 10 Center Drive, MSC 1502, Bethesda, Maryland 20892-1502, USA.

|May 18, 2001

概括

激活互白素-2的免疫疗法可以诱导持久的癌症回归. 识别癌症抗原使新的治疗方法成为可能,促进抗瘤淋巴细胞的有效癌症细胞疗法.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

在转移性黑色素瘤和癌患者中使用介质素-2 (IL-2) 证明了免疫治疗的潜力.
癌症抗原的分子鉴定为新型癌症免疫疗法铺平了道路.
现有研究强调了通过癌症抗原免疫产生抗瘤淋巴细胞的能力.

研究的目的:

探索免疫学操纵在实现持久癌症回归方面的潜力.
研究基于分子识别癌症抗原的有效免疫疗法的开发.
了解癌症逃避免疫反应的机制.

主要方法:

对患有转移性癌症的患者给予介质素-2 .
用来自癌症抗原的酸酶免疫癌症患者.
从免疫患者中分离和体外扩张抗瘤淋巴细胞,用于细胞移植疗法.

主要成果:

经过介质素-2 给药后观察到的转移性癌症的持久回归.
在免疫患者中成功诱导具有抗瘤活性的高水平淋巴细胞.
隔离高度活跃的抗瘤淋巴细胞可用于治疗应用.

结论:

免疫学方法,包括IL-2疗法和抗原特异性免疫,对持久的癌症回归有希望.
需要进一步的研究来阐明癌症的免疫逃生机制,以提高治疗策略.

更多相关视频

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...